F FIVE PRIME THERAPEUTICS INC: management transactions · United States · SEC (Form 4) Browse the full insider trade history of FIVE PRIME THERAPEUTICS INC, a listed issuer based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Market capitalisation: €10.7bn. The latest transaction was disclosed on 8 February 2016 (Levée d'options). Among the most active insiders: Sarena Francis Willard. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 8 February 2016
All Executives25 Thresholds0 Prospectus0 Other0
Declarations 25 total
◇ President and CEO · Executives · 4 Feb 2016
35,615 shares Common Stock SEC:0001123292-16-001685:0
▼ President and CEO · Executives · 4 Feb 2016
20,086 shares Common Stock SEC:0001123292-16-001685:1
▼ President and CEO · Executives · 4 Feb 2016
11,800 shares Common Stock SEC:0001123292-16-001685:2
▼ President and CEO · Executives · 4 Feb 2016
3,729 shares Common Stock SEC:0001123292-16-001685:3
◇ President and CEO · Executives · 4 Feb 2016
35,614 shares Common Stock SEC:0001123292-16-001685:4
▼ President and CEO · Executives · 4 Feb 2016
18,557 shares Common Stock SEC:0001123292-16-001685:5
▼ President and CEO · Executives · 4 Feb 2016
12,408 shares Common Stock SEC:0001123292-16-001685:6
▼ President and CEO · Executives · 4 Feb 2016
4,528 shares Common Stock SEC:0001123292-16-001685:7
▼ President and CEO · Executives · 4 Feb 2016
121 shares Common Stock SEC:0001123292-16-001685:8
◆ SVP, Development Sciences · Executives · 1 Feb 2016
75,000 shares Common Stock SEC:0001123292-16-001673:0
◇ EVP, Gen Counsel & Secretary · Executives · 27 Jan 2016
9,479 shares Common Stock SEC:0001123292-16-001659:0
▼ EVP, Gen Counsel & Secretary · Executives · 27 Jan 2016
6,895 shares Common Stock SEC:0001123292-16-001659:1
▼ EVP, Gen Counsel & Secretary · Executives · 27 Jan 2016
2,584 shares Common Stock SEC:0001123292-16-001659:2
◇ EVP, Gen Counsel & Secretary · Executives · 27 Jan 2016
3,791 shares Common Stock SEC:0001123292-16-001659:3
▼ EVP, Gen Counsel & Secretary · Executives · 27 Jan 2016
3,791 shares Common Stock SEC:0001123292-16-001659:4
◇ EVP, Gen Counsel & Secretary · Executives · 27 Jan 2016
7,449 shares Common Stock SEC:0001123292-16-001659:5
▼ EVP, Gen Counsel & Secretary · Executives · 27 Jan 2016
7,449 shares Common Stock SEC:0001123292-16-001659:6
◇ EVP, Gen Counsel & Secretary · Executives · 27 Jan 2016
7,768 shares Common Stock SEC:0001123292-16-001659:7
▼ EVP, Gen Counsel & Secretary · Executives · 27 Jan 2016
7,768 shares Common Stock SEC:0001123292-16-001659:8
◇ EVP, Gen Counsel & Secretary · Executives · 27 Jan 2016
1,513 shares Common Stock SEC:0001123292-16-001659:9
▼ EVP, Gen Counsel & Secretary · Executives · 27 Jan 2016
1,513 shares Common Stock SEC:0001123292-16-001659:10
◇ Director · Executives · 11 Jan 2016
4,065 shares Common Stock SEC:0001123292-16-001556:0
◇ Director · Executives · 11 Jan 2016
4,065 shares Common Stock SEC:0001123292-16-001556:1
◇ Director · Executives · 11 Jan 2016
4,065 shares Common Stock SEC:0001123292-16-001556:2
◇ Director · Executives · 11 Jan 2016
12,500 shares Common Stock SEC:0001123292-16-001556:3